Anaptysbio (ANAB) Equity Ratio (2016 - 2025)
Anaptysbio (ANAB) has disclosed Equity Ratio for 10 consecutive years, with 0.1 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 30.28% year-over-year to 0.1, compared with a TTM value of 0.1 through Dec 2025, down 30.28%, and an annual FY2025 reading of 0.1, down 30.28% over the prior year.
- Equity Ratio was 0.1 for Q4 2025 at Anaptysbio, up from 0.08 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.96 in Q1 2021 and bottomed at 0.13 in Q2 2025.
- Average Equity Ratio over 5 years is 0.34, with a median of 0.27 recorded in 2023.
- The sharpest move saw Equity Ratio rose 2.04% in 2021, then plummeted 677.24% in 2025.
- Year by year, Equity Ratio stood at 0.55 in 2021, then dropped by 22.53% to 0.43 in 2022, then crashed by 54.65% to 0.19 in 2023, then decreased by 24.79% to 0.15 in 2024, then plummeted by 30.28% to 0.1 in 2025.
- Business Quant data shows Equity Ratio for ANAB at 0.1 in Q4 2025, 0.08 in Q3 2025, and 0.13 in Q2 2025.